Prism Venture Management
VC Fund
Needham, United States
Prism Venture Management is a VC fund in Needham focused on Health Care and Medical. Prism Ventureworks has 5 funds with $1.25 billion in investments. Their most recent fund is for $250M which was raised in June 2005.Each of their team members focuses on different industry sectors within technology and life sciences. These industry sectors in technology include the digital living, wireless, mobile and telecommunicationsmarkets, as well as promising opportunities in next-generation data centers and on-demand and security applications. In life sciences, we focus on medical devices, therapeutics and breakthrough diagnostics.
- Total investments:
- 124
- Last investment:
- Lead investor:
- 28%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Prism Venture Management invests in
Stages Prism Venture Management invests in
Countries Prism Venture Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series A
- $4M–$14M
- Series B
- $7M–$31M
- Series C
- $8M–$35M
Investment Focus
Industry
- Health Care 21 (17%)
- Medical 13 (10%)
- Biotechnology 13 (10%)
- Medical Device 12 (10%)
- Software 11 (9%)
Stage
- Series A 27 (22%)
- Series C 26 (21%)
- Series B 23 (19%)
- Funding Round 15 (12%)
- Series D 14 (11%)
Country
- United States 61 (49%)
- Canada 2 (2%)
- Spain 1 (1%)
- Vietnam 1 (1%)
- Hong Kong 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jim Counihan
General Partner & Managing Director
|
General Partner & Managing Director | Total investments: 15 | Find email | |
Anthony Natale
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Bong Koh
Team Member
|
Team Member | Total investments: 4 | Find email | |
|
Duane Mason
Co-founder and General Partner
|
Co-founder and General Partner | Total investments: 0 | Find email | |
James Counihan
General Partner and Managing Director
|
General Partner and Managing Director | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Osteal Therapeutics is a clinical-stage specialty pharmaceutical company developing novel drug and device combination products for treating musculoskeletal infection. | $23M / Series C / Sep 21, 2023 | ||
| Revation is an eco-friendly product development company that focuses on environmental issues through design and technology. | $675.3K / Seed / Jun 21, 2023 | ||
| Jeff is a company created in 2015 by Eloi Gómez, Adrián Lorenzo and Rubén Muñoz, three Spanish entrepreneurs. It started as a home laundry and dry-cleaning app, but is currently in an expansion process in which, in addition to laundry service, different day-to-day services are added such as hairdressing and beauty, fitness and massages, becomingthe first international omnichannel ecosystem of day-to-day services. It is available to anyone who wants to invest or undertake the necessary solutions to launch their own business under the business lines of the Jeff brand. | $48.6M / Series C / Feb 03, 2023 | ||
| Aigens is a tech start-up that has helped steer the digital revolution of the F&B and Hospitality industry in Asia Pacific. The company led the way with mobile ordering and popularized scan-to-order long before Covid-19 triggered the mainstream adoption of their use.Founded in 2012 by Hans Paul (CEO) and Peter Liu (CTO), Aigens has grown intoa SaaS company known for being a market leader with significant wins, essentially being the first to introduce BYOD (Bring Your Own Device) QR code ordering technology to Hong Kong and Singapore.Headquartered in Hong Kong, Aigens serves more than 500 brands in F&B and Hospitality, including global names like KFC, Burger King, Starbucks, and IKEA. In the last three years, the company experienced its most significant growth, resulting in 6 regional offices and 120 team members. | $14M / Series A / Dec 05, 2022 | ||
| Lozi is the fastest-growing Tech startup that operates a one-hour-delivery E-commerce platform called Loship. Made by Vietnamese for Vietnamese, Loship offers the most effective distribution networks in Vietnam, filling the massive demand for immediate deliveries in a bustling and modern life, with a wide range of services including food delivery(Loship), grocery delivery (Lomart), ride-hailing (Lo-xe), medicine delivery (Lomed), laundry service (Lozat), package delivery (Lo-send), beauty products delivery (LoBeauty), flower delivery (Lo-hoa) and B2B supply delivery (Lo-supply).Loship now has a fleet of more than 70,000 drivers and 200,000 merchants, serving almost 2,000,000 customers across four big cities of Hanoi, Ho Chi Minh City, Da Nang and Can Tho – all dedicated to fulfilling the Vietnamese consumers’ one-hour delivery needs. | $12M / Series C / Aug 03, 2021 | ||
| Babson Diagnostics is an operator of a healthcare technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter. The company develops a model for the blood test that requires only one-tenth of the sample size of traditional venipuncture methods, that enable consumers to get laboratory-grade bloodwork done within ashort wait time. | $31M / Series B / Jun 29, 2021 | ||
| Babson Diagnostics is an operator of a healthcare technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter. The company develops a model for the blood test that requires only one-tenth of the sample size of traditional venipuncture methods, that enable consumers to get laboratory-grade bloodwork done within ashort wait time. | $13.7M / Series A / Sep 24, 2020 | ||
| Covera Health is a clinical analytics company, is pioneering quality-based solutions for payers and providers that enable the measurement and delivery of high-quality care. The company's services include analyzing clinical datasets in unique ways to drive the emerging science of quality and partner with doctors to help them deliver, enablingemployers and payers to improve patient outcomes and reduce inappropriate healthcare spend. | $23.5M / Series B / Jan 09, 2020 | ||
| Connotate transforms web data and content into high-value information assets -- to feed content products, grow market and business intelligence, enable mass data aggregation, migration and integration. Connotate's patented intelligent Agent technology empowers both business users and programmers to quickly create data sets, newapplications and content products. With Connotate, customers experience productivity gains, reduced costs, mitigated risks, more informed decision-making and strategic & competitive advantages. | $11M / Series B / Nov 17, 2016 | ||
| Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.Proteon Therapeutics’ first drug candidate (PRT-201) is indevelopment for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD). | $45M / Series D / May 16, 2014 | ||
| See all 124 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Prism Venture Management invest in?
Prism Venture Management invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series C stage. Most of the 124 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Prism Venture Management invest in?
Prism Venture Management typically joins rounds of $4M–$14M at Series A, $7M–$31M at Series B and $8M–$35M at Series C. These are whole funding-round sizes, not Prism Venture Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Prism Venture Management took part in.
How do I contact Prism Venture Management?
Public channels for Prism Venture Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Prism Venture Management?
The team at Prism Venture Management includes Jim Counihan (General Partner & Managing Director), Anthony Natale (Venture Partner) and Bong Koh (Team Member), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
